Cargando…

Fixed ratio dosing of pramlintide with regular insulin before a standard meal in patients with type 1 diabetes

Amylin is co‐secreted with insulin and is therefore lacking in patients with type 1 diabetes. Replacement with fixed ratio co‐administration of insulin and the amylin analogue pramlintide may be superior to separate dosing. This concept was evaluated in a ratio‐finding study. Patients with type 1 di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riddle, M. C., Yuen, K. C. J., de Bruin, T. W., Herrmann, K., Xu, J., Öhman, P., Kolterman, O. G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2015
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758401/ https://www.ncbi.nlm.nih.gov/pubmed/26040429 http://dx.doi.org/10.1111/dom.12504

Ejemplares similares

A co-formulation of supramolecularly stabilized insulin and pramlintide enhances meal-time glucagon suppression in diabetic pigs
por: Maikawa, Caitlin L., et al.
Publicado: (2020)

Randomized Comparison of Pramlintide or Mealtime Insulin Added to Basal Insulin Treatment for Patients With Type 2 Diabetes
por: Riddle, Matthew, et al.
Publicado: (2009)

Pramlintide in the Management of Insulin-Using Patients with Type 2 and Type 1 Diabetes
por: Pullman, John, et al.
Publicado: (2006)

Ultra‐Fast Insulin–Pramlintide Co‐Formulation for Improved Glucose Management in Diabetic Rats
por: Maikawa, Caitlin L., et al.
Publicado: (2021)

Cardiovascular safety assessment of pramlintide in type 2 diabetes: results from a pooled analysis of five clinical trials
por: Herrmann, Kathrin, et al.
Publicado: (2016)

A Phase 2 Evaluation of a Novel Co-Formulation of Pramlintide and Regular Insulin to Improve Postprandial Glycemic Control in Adults with Type 1 Diabetes (T1D)
por: Edelman, Steven Victor, et al.
Publicado: (2021)

SAT-LB028 Efficacy and Safety of Pramlintide as an Adjunct to Insulin U500 Therapy in Veterans with Severe Insulin Resistance
por: Oprea, Mihaela, et al.
Publicado: (2019)

Influence of a Regular, Standardized Meal on Clinical Chemistry Analytes
por: Lima-Oliveira, Gabriel, et al.
Publicado: (2012)

Pramlintide, an antidiabetic, is antineoplastic in colorectal cancer and synergizes with conventional chemotherapy
por: Al-Keilani, Maha S, et al.
Publicado: (2018)

Impact of Disease Duration on the Effects of Pramlintide in Type 1 Diabetes: A Post Hoc Analysis of Three Clinical Trials
por: Herrmann, Kathrin, et al.
Publicado: (2016)

The effect of pramlintide, an antidiabetic amylin analogue, on angiogenesis-related markers in vitro
por: Safaeian, Leila, et al.
Publicado: (2020)

Pramlintide: A Novel Therapeutic Approach for Osteosarcoma through Metabolic Reprogramming
por: Yang, Yuanzheng, et al.
Publicado: (2022)

Study of forced degradation behavior of pramlintide acetate by HPLC and LC–MS
por: Yuan, Yu, et al.
Publicado: (2017)

Sustained Weight Loss Following 12-Month Pramlintide Treatment as an Adjunct to Lifestyle Intervention in Obesity
por: Smith, Steve R., et al.
Publicado: (2008)

Review of pramlintide as adjunctive therapy in treatment of type 1 and type 2 diabetes
por: Ryan, Gina, et al.
Publicado: (2009)

Amylin and pramlintide modulate γ-secretase level and APP processing in lipid rafts
por: Mousa, Youssef M., et al.
Publicado: (2020)

Inhaled insulin: A “puff” than a “shot” before meals
por: Brashier, Dick B. S., et al.
Publicado: (2015)

Efficacy and safety of pramlintide injection adjunct to insulin therapy in patients with type 1 diabetes mellitus: a systematic review and meta-analysis
por: Qiao, Yong-Chao, et al.
Publicado: (2017)

Contraction of human brain vascular pericytes in response to islet amyloid polypeptide is reversed by pramlintide
por: Nuñez-Diaz, Cristina, et al.
Publicado: (2023)

Insulin in Type 1 and Type 2 Diabetes—Should the Dose of Insulin Before a Meal be Based on Glycemia or Meal Content?
por: Krzymien, Janusz, et al.
Publicado: (2019)

Development and validation of a new robust RP-HPLC method for simultaneous quantitation of insulin and pramlintide in non-invasive and smart glucose-responsive microparticles
por: Emami, Jaber, et al.
Publicado: (2022)

Author Correction: Amylin and pramlintide modulate γ-secretase level and APP processing in lipid rafts
por: Mousa, Youssef M., et al.
Publicado: (2020)

Zn(II) binding to pramlintide results in a structural kink, fibril formation and antifungal activity
por: Dudek, Dorota, et al.
Publicado: (2022)

Erratum: Inhaled insulin: A “puff” than a “shot” before meals
Publicado: (2015)

Meal Regularity Plays a Role in Shaping the Saliva Microbiota
por: Viljakainen, Jannina, et al.
Publicado: (2020)

Injectable Biodegradable Silica Depot: Two Months of Sustained Release of the Blood Glucose Lowering Peptide, Pramlintide
por: Tyagi, Puneet, et al.
Publicado: (2022)

Pharmacokinetics and Pharmacodynamics of High-Dose Human Regular U-500 Insulin Versus Human Regular U-100 Insulin in Healthy Obese Subjects
por: de la Peña, Amparo, et al.
Publicado: (2011)

Dual treatment with a fixed ratio of glucagon and insulin increases the therapeutic window of insulin in diabetic rats
por: Pedersen, Christina, et al.
Publicado: (2018)

Pramlintide, the synthetic analogue of amylin: physiology, pathophysiology, and effects on glycemic control, body weight, and selected biomarkers of vascular risk
por: Hoogwerf, Byron J, et al.
Publicado: (2008)

Pramlintide regulation of extracellular matrix (ECM) and apoptosis through mitochondrial-dependent pathways in human nucleus pulposus cells
por: Wu, Xinghuo, et al.
Publicado: (2017)

Effect of Pramlintide on Prandial Glycemic Excursions During Closed-Loop Control in Adolescents and Young Adults With Type 1 Diabetes
por: Weinzimer, Stuart A., et al.
Publicado: (2012)

A Definition of “Regular Meals” Driven by Dietary Quality Supports a Pragmatic Schedule
por: Lohse, Barbara, et al.
Publicado: (2020)

Rapid-acting and Regular Insulin are Equal for High Fat-Protein Meal in Individuals with Type 1 Diabetes Treated with Multiple Daily Injections
por: Jabłońska, Karolina, et al.
Publicado: (2018)

GOLD and the fixed ratio
por: Vestbo, Jørgen
Publicado: (2012)

Fixed-Ratio Combinations
por: Tran, Emmeline
Publicado: (2017)

Comparative pharmacodynamic and pharmacokinetic characteristics of subcutaneous insulin glulisine and insulin aspart prior to a standard meal in obese subjects with type 2 diabetes
por: Bolli, G B, et al.
Publicado: (2011)

Pramlintide: An Amylin Analogue Protects Endothelial Cells against Oxidative Stress through Regulating Oxidative Markers and NF-κb Expression
por: Safaeian, Leila, et al.
Publicado: (2022)

Free boundary problems: regularity properties near the fixed boundary
por: Apushkinskaya, Darya
Publicado: (2018)

REGULARITY OF RECURRENCE OF FIXED DRUG ERUPTION: A POINTER TO THE CAUSE
por: Ambooken, Betsy, et al.
Publicado: (2009)

Postprandial blood glucose response to a standard test meal in insulin-requiring patients with diabetes treated with insulin lispro mix 50 or human insulin mix 50
por: Gao, Y, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_0ubjr42ftlakh6jmr8745g1k7g